These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15713229)

  • 1. An in vitro evaluation of standard rotational thromboelastography in monitoring of effects of recombinant factor VIIa on coagulopathy induced by hydroxy ethyl starch.
    Engström M; Reinstrup P; Schött U
    BMC Blood Disord; 2005 Feb; 5(1):3. PubMed ID: 15713229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hemodilution on coagulation and recombinant factor VIIa efficacy in human blood in vitro.
    Darlington DN; Delgado AV; Kheirabadi BS; Fedyk CG; Scherer MR; Pusateri AE; Wade CE; Cap AP; Holcomb JB; Dubick MA
    J Trauma; 2011 Nov; 71(5):1152-63. PubMed ID: 21610535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prohemostatic Activity of Factor X in Combination With Activated Factor VII in Dilutional Coagulopathy.
    Takeshita S; Ogawa S; Nakayama Y; Mukai N; Nakajima Y; Mizobe T; Sawa T; Tanaka KA
    Anesth Analg; 2019 Aug; 129(2):339-345. PubMed ID: 30320649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring recombinant factor VIIa treatment: efficacy depends on high levels of fibrinogen in a model of severe dilutional coagulopathy.
    Ganter MT; Schmuck S; Hamiel CR; Wischmeyer PE; Heule D; Zollinger A; Hofer CK
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):675-80. PubMed ID: 18922422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of In vitro hemodilution, hypothermia and rFVIIa addition on coagulation in human blood.
    Darlington DN; Kremenevskiy I; Pusateri AE; Scherer MR; Fedyk CG; Kheirabaldi BS; Delgado AV; Dubick MA
    Int J Burns Trauma; 2012; 2(1):42-50. PubMed ID: 22928166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.
    Dickneite G; Dörr B; Kaspereit F; Tanaka KA
    J Trauma; 2010 May; 68(5):1151-7. PubMed ID: 19996804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citrate artificially masks the haemostatic effect of recombinant factor VIIa in dilutional coagulopathy.
    Fenger-Eriksen C; Ingerslev J; Tønnesen E; Sørensen B
    Ann Hematol; 2009 Mar; 88(3):255-60. PubMed ID: 18696068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
    Kwon JO; MacLaren R
    Pharmacotherapy; 2016 Oct; 36(10):1047-1054. PubMed ID: 27547916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and monitoring of recombinant activated factor VII.
    Ingerslev J; Christiansen K; Calatzis A; Holm M; Sabroe Ebbesen L
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S25-30. PubMed ID: 10850560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant factor VIIa and fibrinogen display additive effect during in vitro haemodilution with crystalloids.
    Fenger-Eriksen C; Tønnesen E; Ingerslev J; Sørensen B
    Acta Anaesthesiol Scand; 2009 Mar; 53(3):332-8. PubMed ID: 19243319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effect of activated recombinant factor VII (rFVIIa) on coagulation properties of human blood at hypothermic temperatures.
    Kheirabadi BS; Delgado AV; Dubick MA; Scherer MR; Fedyk CG; Holcomb JB; Pusateri AE
    J Trauma; 2007 Nov; 63(5):1079-86. PubMed ID: 17993954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant factor VIIa is effective at reversing coagulopathy in a lactic acidosis model.
    Lesperance RN; Lehmann RK; Harold DM; Beekley AC; Sebesta JA; Martin MJ
    J Trauma Acute Care Surg; 2012 Jan; 72(1):123-9. PubMed ID: 22002618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Step Toward Balance: Thrombin Generation Improvement via Procoagulant Factor and Antithrombin Supplementation.
    Mitrophanov AY; Szlam F; Sniecinski RM; Levy JH; Reifman J
    Anesth Analg; 2016 Sep; 123(3):535-46. PubMed ID: 27541717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A.
    Sørensen B; Persson E; Ingerslev J
    Br J Haematol; 2007 Apr; 137(2):158-65. PubMed ID: 17391496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of increasing doses of activated recombinant factor VII on haemostatic parameters in swine.
    Pusateri AE; Ryan KL; Delgado AV; Martinez RS; Uscilowicz JM; Cortez DS; Martinowitz U
    Thromb Haemost; 2005 Feb; 93(2):275-83. PubMed ID: 15711743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. rFVIIa and NN1731 reduce bleeding in hydroxyethyl starch hemodiluted rabbits.
    Lauritzen B; Viuff D; Tranholm M; Ezban M
    J Trauma; 2010 Nov; 69(5):1196-202. PubMed ID: 20032791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia.
    Spronk HM; Braunschweig T; Rossaint R; Wüst DC; van Oerle R; Lauritzen B; Tolba R; Grottke O
    PLoS One; 2015; 10(6):e0113979. PubMed ID: 26098426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation.
    Hendriks HG; Meijer K; de Wolf JT; Porte RJ; Klompmaker IJ; Lip H; Slooff MJ; van der Meer J
    Blood Coagul Fibrinolysis; 2002 Jun; 13(4):309-13. PubMed ID: 12032396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose recombinant factor VIIa for reversing coagulopathy in patients with isolated traumatic brain injury.
    Yuan Q; Wu X; Du ZY; Sun YR; Yu J; Li ZQ; Wu XH; Mao Y; Zhou LF; Hu J
    J Crit Care; 2015 Feb; 30(1):116-20. PubMed ID: 25092615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma.
    Pusateri AE; Park MS
    Crit Care; 2005; 9 Suppl 5(Suppl 5):S15-24. PubMed ID: 16221315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.